Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Drug Discovery of the Year Opens for Nominations

Published: Monday, May 27, 2013
Last Updated: Sunday, May 26, 2013
Bookmark and Share
Judges welcome submissions from across the spectrum of pharmacology.

The British Pharmacological Society (BPS) has announced that it is now accepting nominations for its Drug Discovery of the Year award.

The award was established by BPS to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover new drugs.

Drug Discovery of the Year was presented last year to the team who developed vismodegib for the treatment of advanced basal cell carcinoma.

The announcement followed judging by the BPS Industry Committee, consisting of experts in industrial pharmacology, who reviewed nominations from across the world and a range of disease areas.

Professor Philip Routledge, BPS President, comments: “I am delighted to announce the details of Drug Discovery of the Year and to welcome submissions from across the whole spectrum of pharmacology. BPS intends to build on the number and high quality of the nominations received in 2012, all of which demonstrated the importance of pharmacology in drug discovery.”

This year, BPS Industry Committee will consider nominations for the discovery team behind a drug - whether a large or a small molecule - that best fulfils the following criteria:
• gained regulatory approval within the last three years in the EU and/or US
• preclinical to clinical translation shows the importance of pharmacology in the drug discovery/development process
• has a significant impact on an unmet medical need
• first-in-class, or is a significant improvement over other drugs in the class
• mechanism of action known

Nominations must be received by 1 October 2013. The winning team will be publicly announced during the BPS flagship meeting Pharmacology 2013, held in London 17-19 December 2013 and attended by an anticipated 1,000 pharmacologists.

The award neither promotes the administration, consumption, prescription, purchase, recommendation, sale, supply or use of the winning medicine; nor does it pre-empt any regulatory decisions.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!